September 26, 2024 09:00 PM EDTUpdated 01:03 PM
Startups
Special

End­points 11 win­ner Met­sera: Clive Mean­well wa­gers on obe­si­ty af­ter Med­i­cines Com­pa­ny suc­cess

Kyle LaHucik

Senior Reporter

↑
  • CEO Clive Mean­well
  • To­tal raised $290 mil­lion
  • Head­quar­ters New York, NY

Short­ly af­ter Clive Mean­well sold The Med­i­cines Com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

A service from the Financial Times